Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Active, not recruiting	Phase 2	2026-05-06		NCT01840592

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bayer	178
Memorial Sloan Kettering Cancer Center	753
National Comprehensive Cancer Network	27

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Memorial Sloan Kettering Cancer Center @ Suffolk	Commack	United States	14
Memorial Sloan Kettering Cancer Center at Basking Ridge	Basking Ridge	United States	1
Memorial Sloan Kettering Cancer Center at Mercy Medical Center	Rockville Centre	United States	1
Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center	Sleepy Hollow	United States	2
Memorial Sloan Kettering West Harrison	Harrison	United States	3